BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.380
-0.010 (-0.42%)
Nov 4, 2024, 4:00 PM EST - Market closed

BioCardia Revenue

BioCardia had revenue of $3.00K in the quarter ending June 30, 2024, a decrease of -93.02%. This brings the company's revenue in the last twelve months to $428.00K, up 0.71% year-over-year. In the year 2023, BioCardia had annual revenue of $477.00K, down -64.72%.

Revenue (ttm)
$428.00K
Revenue Growth
+0.71%
P/S Ratio
9.03
Revenue / Employee
$21,400
Employees
20
Market Cap
8.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023477.00K-875.00K-64.72%
Dec 31, 20221.35M337.00K33.20%
Dec 31, 20211.02M870.00K600.00%
Dec 31, 2020145.00K-565.00K-79.58%
Dec 31, 2019710.00K85.00K13.60%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
XWELL 32.88M
Streamline Health Solutions 20.30M
Ensysce Biosciences 1.44M
Soligenix 494.62K
Vaccinex 356.00K
Virax Biolabs Group 156.42K
Cardio Diagnostics Holdings 39.14K
Revenue Rankings